Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation.

F1000Research

Arshad F, Adelmeijer J, Blokzijl H, van den Berg A, Porte R, Lisman T.
PMID: 25285204
F1000Res. 2014 May 09;3:103. doi: 10.12688/f1000research.3980.1. eCollection 2014.

BACKGROUND: The long-term risk of thrombotic and vascular complications is elevated in liver transplant recipients compared to the general population. Patients with cirrhosis are in a hypercoagulable status during and directly after orthotopic liver transplantation, but it is unclear...

Cite
Arshad F, Adelmeijer J, Blokzijl H, et al. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Res. 2014;3:103doi: 10.12688/f1000research.3980.1.
Arshad, F., Adelmeijer, J., Blokzijl, H., van den Berg, A., Porte, R., & Lisman, T. (2014). Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Research, 3103. https://doi.org/10.12688/f1000research.3980.1
Arshad, Freeha, et al. "Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation." F1000Research vol. 3 (2014): 103. doi: https://doi.org/10.12688/f1000research.3980.1
Arshad F, Adelmeijer J, Blokzijl H, van den Berg A, Porte R, Lisman T. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Res. 2014 May 09;3:103. doi: 10.12688/f1000research.3980.1. eCollection 2014. PMID: 25285204.
Copy Download .nbib Format: NLM
Inulin-grown .

Gut microbes

Fagundes RR, Bourgonje AR, Saeed A, Vich Vila A, Plomp N, Blokzijl T, Sadaghian Sadabad M, von Martels JZH, van Leeuwen SS, Weersma RK, Dijkstra G, Harmsen HJM, Faber KN.
PMID: 34793284
Gut Microbes. 2021 Jan-Dec;13(1):1993582. doi: 10.1080/19490976.2021.1993582.

Many chronic diseases are associated with decreased abundance of the gut commensal

Cite
Fagundes RR, Bourgonje AR, Saeed A, et al. Inulin-grown . Gut Microbes. 2021;13(1):1993582doi: 10.1080/19490976.2021.1993582.
Fagundes, R. R., Bourgonje, A. R., Saeed, A., Vich Vila, A., Plomp, N., Blokzijl, T., Sadaghian Sadabad, M., von Martels, J. Z. H., van Leeuwen, S. S., Weersma, R. K., Dijkstra, G., Harmsen, H. J. M., & Faber, K. N. (2021). Inulin-grown . Gut microbes, 13(1), 1993582. https://doi.org/10.1080/19490976.2021.1993582
Fagundes, Raphael R, et al. "Inulin-grown ." Gut microbes vol. 13,1 (2021): 1993582. doi: https://doi.org/10.1080/19490976.2021.1993582
Fagundes RR, Bourgonje AR, Saeed A, Vich Vila A, Plomp N, Blokzijl T, Sadaghian Sadabad M, von Martels JZH, van Leeuwen SS, Weersma RK, Dijkstra G, Harmsen HJM, Faber KN. Inulin-grown . Gut Microbes. 2021 Jan-Dec;13(1):1993582. doi: 10.1080/19490976.2021.1993582. PMID: 34793284; PMCID: PMC8604389.
Copy Download .nbib Format: NLM
Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

United European gastroenterology journal

Meijer B, Simsek M, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CM, Mulder CJ, de Boer NK.
PMID: 28815029
United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16.

BACKGROUND: Nodular regenerative hyperplasia is an uncommon liver condition associated with several autoimmune disorders and drugs. The clinical symptoms of nodular regenerative hyperplasia vary from asymptomatic to severe complications of portal hypertension (nodular regenerative hyperplasia-syndrome).OBJECTIVE: The purpose of this...

Cite
Meijer B, Simsek M, Blokzijl H, et al. Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European Gastroenterol J. 2016;5(5):658-667doi: 10.1177/2050640616680550.
Meijer, B., Simsek, M., Blokzijl, H., de Man, R. A., Coenraad, M. J., Dijkstra, G., van Nieuwkerk, C. M., Mulder, C. J., & de Boer, N. K. (2017). Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European gastroenterology journal, 5(5), 658-667. https://doi.org/10.1177/2050640616680550
Meijer, Berrie, et al. "Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units." United European gastroenterology journal vol. 5,5 (2017): 658-667. doi: https://doi.org/10.1177/2050640616680550
Meijer B, Simsek M, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CM, Mulder CJ, de Boer NK. Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16. PMID: 28815029; PMCID: PMC5548351.
Copy Download .nbib Format: NLM
Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients.

Journal of clinical medicine

Douwes RM, Gomes-Neto AW, Schutten JC, van den Berg E, de Borst MH, Berger SP, Touw DJ, Hak E, Blokzijl H, Navis G, Bakker SJL.
PMID: 31817776
J Clin Med. 2019 Dec 06;8(12). doi: 10.3390/jcm8122162.

Proton-pump inhibitors (PPIs) are commonly used after kidney transplantation and there is rarely an incentive to discontinue treatment. In the general population, PPI use has been associated with hypomagnesaemia. We aimed to investigate whether PPI use is associated with...

Cite
Douwes RM, Gomes-Neto AW, Schutten JC, et al. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients. J Clin Med. 2019;8(12)doi: 10.3390/jcm8122162.
Douwes, R. M., Gomes-Neto, A. W., Schutten, J. C., van den Berg, E., de Borst, M. H., Berger, S. P., Touw, D. J., Hak, E., Blokzijl, H., Navis, G., & Bakker, S. J. L. (2019). Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients. Journal of clinical medicine, 8(12), . https://doi.org/10.3390/jcm8122162
Douwes, Rianne M, et al. "Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients." Journal of clinical medicine vol. 8,12 (2019). doi: https://doi.org/10.3390/jcm8122162
Douwes RM, Gomes-Neto AW, Schutten JC, van den Berg E, de Borst MH, Berger SP, Touw DJ, Hak E, Blokzijl H, Navis G, Bakker SJL. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients. J Clin Med. 2019 Dec 06;8(12). doi: 10.3390/jcm8122162. PMID: 31817776; PMCID: PMC6947083.
Copy Download .nbib Format: NLM
Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report.

Clinical transplants

de Vries Y, de Jong IEM, Berendsen TA, Lisman T, Verkade HJ, Scheenstra R, Reyntjens KMEM, de Boer MT, Blokzijl J, Peeters PMG, van den Berg AP, Porte RJ.
PMID: 28514572
Clin Transpl. 2015;31:101-111.

The liver transplantation program of the University Medical Center Groningen in the Netherlands was started in 1979, making it one of the first programs worldwide. During the past 36 years, a total of 1478 liver transplantations have been performed,...

Cite
de Vries Y, de Jong IEM, Berendsen TA, et al. Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report. Clin Transpl. 2015;31:101-111
de Vries, Y., de Jong, I. E. M., Berendsen, T. A., Lisman, T., Verkade, H. J., Scheenstra, R., Reyntjens, K. M. E. M., de Boer, M. T., Blokzijl, J., Peeters, P. M. G., van den Berg, A. P., & Porte, R. J. (2015). Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report. Clinical transplants, 31101-111.
de Vries, Yvonne, et al. "Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report." Clinical transplants vol. 31 (2015): 101-111.
de Vries Y, de Jong IEM, Berendsen TA, Lisman T, Verkade HJ, Scheenstra R, Reyntjens KMEM, de Boer MT, Blokzijl J, Peeters PMG, van den Berg AP, Porte RJ. Liver Transplantation in Groningen, The Netherlands: A Single Center Status Report. Clin Transpl. 2015;31:101-111. PMID: 28514572.
Copy Download .nbib Format: NLM
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation.

F1000Research

Arshad F, Adelmeijer J, Blokzijl H, van den Berg A, Porte R, Lisman T.
PMID: 25285204
F1000Res. 2014 May 09;3:103. doi: 10.12688/f1000research.3980.2. eCollection 2014.

BACKGROUND: The long-term risk of thrombotic and vascular complications is elevated in liver transplant recipients compared to the general population. Patients with cirrhosis are in a hypercoagulable status during and directly after orthotopic liver transplantation, but it is unclear...

Cite
Arshad F, Adelmeijer J, Blokzijl H, et al. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Res. 2014;3:103doi: 10.12688/f1000research.3980.2.
Arshad, F., Adelmeijer, J., Blokzijl, H., van den Berg, A., Porte, R., & Lisman, T. (2014). Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Research, 3103. https://doi.org/10.12688/f1000research.3980.2
Arshad, Freeha, et al. "Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation." F1000Research vol. 3 (2014): 103. doi: https://doi.org/10.12688/f1000research.3980.2
Arshad F, Adelmeijer J, Blokzijl H, van den Berg A, Porte R, Lisman T. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000Res. 2014 May 09;3:103. doi: 10.12688/f1000research.3980.2. eCollection 2014. PMID: 25285204; PMCID: PMC4176425.
Copy Download .nbib Format: NLM
Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma.

Case reports in gastroenterology

Hepkema JT, Poelmann FB, Gouw ASH, de Haas RJ, Duiker EW, Blokzijl H, Klaase JM.
PMID: 33250700
Case Rep Gastroenterol. 2020 Nov 02;14(3):577-585. doi: 10.1159/000510215. eCollection 2020.

Hepatocellular adenomas (HCA) are rare benign tumors of the liver, occurring predominantly in females using oral contraceptives. Our case describes a 66-year-old woman presenting with a palpable mass in her upper abdomen. Contrast-enhanced computed tomography and magnetic resonance imaging...

Cite
Hepkema JT, Poelmann FB, Gouw ASH, et al. Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma. Case Rep Gastroenterol. 2020;14(3):577-585doi: 10.1159/000510215.
Hepkema, J. T., Poelmann, F. B., Gouw, A. S. H., de Haas, R. J., Duiker, E. W., Blokzijl, H., & Klaase, J. M. (2020). Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma. Case reports in gastroenterology, 14(3), 577-585. https://doi.org/10.1159/000510215
Hepkema, Joris T, et al. "Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma." Case reports in gastroenterology vol. 14,3 (2020): 577-585. doi: https://doi.org/10.1159/000510215
Hepkema JT, Poelmann FB, Gouw ASH, de Haas RJ, Duiker EW, Blokzijl H, Klaase JM. Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma. Case Rep Gastroenterol. 2020 Nov 02;14(3):577-585. doi: 10.1159/000510215. eCollection 2020. PMID: 33250700; PMCID: PMC7670361.
Copy Download .nbib Format: NLM
Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease.

Journal of Crohn's & colitis

van der Sloot KWJ, Voskuil MD, Blokzijl T, Dinkla A, Ravesloot L, Visschedijk MC, van Dullemen HM, Festen EAM, Alizadeh BZ, van Leer-Buter C, Weersma RK, van Goor H, Koets AP, Dijkstra G.
PMID: 33378524
J Crohns Colitis. 2021 Aug 02;15(8):1253-1263. doi: 10.1093/ecco-jcc/jjaa263.

BACKGROUND: The role of Mycobacterium avium paratuberculosis [MAP] in inflammatory bowel disease [IBD], especially Crohn's disease [CD] is controversial due conflicting results and lack of reproducibility and standardised tests. The current study focuses on the role of MAP in...

Cite
van der Sloot KWJ, Voskuil MD, Blokzijl T, et al. Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease. J Crohns Colitis. 2021;15(8):1253-1263doi: 10.1093/ecco-jcc/jjaa263.
van der Sloot, K. W. J., Voskuil, M. D., Blokzijl, T., Dinkla, A., Ravesloot, L., Visschedijk, M. C., van Dullemen, H. M., Festen, E. A. M., Alizadeh, B. Z., van Leer-Buter, C., Weersma, R. K., van Goor, H., Koets, A. P., & Dijkstra, G. (2021). Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease. Journal of Crohn's & colitis, 15(8), 1253-1263. https://doi.org/10.1093/ecco-jcc/jjaa263
van der Sloot, Kimberley W J, et al. "Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease." Journal of Crohn's & colitis vol. 15,8 (2021): 1253-1263. doi: https://doi.org/10.1093/ecco-jcc/jjaa263
van der Sloot KWJ, Voskuil MD, Blokzijl T, Dinkla A, Ravesloot L, Visschedijk MC, van Dullemen HM, Festen EAM, Alizadeh BZ, van Leer-Buter C, Weersma RK, van Goor H, Koets AP, Dijkstra G. Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease. J Crohns Colitis. 2021 Aug 02;15(8):1253-1263. doi: 10.1093/ecco-jcc/jjaa263. PMID: 33378524; PMCID: PMC8496491.
Copy Download .nbib Format: NLM
Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study.

Open forum infectious diseases

Isfordink CJ, van de Laar TJW, Rebers SPH, Wessels E, Molenkamp R, Knoester M, Baak BC, van Nieuwkoop C, van Hoek B, Brakenhoff SM, Blokzijl H, Arends JE, van der Valk M, Schinkel J.
PMID: 33614815
Open Forum Infect Dis. 2021 Jan 06;8(2):ofab006. doi: 10.1093/ofid/ofab006. eCollection 2021 Feb.

BACKGROUND: The majority of hepatitis C virus (HCV) infections are found in low- and middle-income countries, which harbor many region-specific HCV subtypes. Nevertheless, direct-acting antiviral (DAA) trials have almost exclusively been conducted in high-income countries, where mainly epidemically spread...

Cite
Isfordink CJ, van de Laar TJW, Rebers SPH, et al. Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study. Open Forum Infect Dis. 2021;8(2):ofab006doi: 10.1093/ofid/ofab006.
Isfordink, C. J., van de Laar, T. J. W., Rebers, S. P. H., Wessels, E., Molenkamp, R., Knoester, M., Baak, B. C., van Nieuwkoop, C., van Hoek, B., Brakenhoff, S. M., Blokzijl, H., Arends, J. E., van der Valk, M., & Schinkel, J. (2021). Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study. Open forum infectious diseases, 8(2), ofab006. https://doi.org/10.1093/ofid/ofab006
Isfordink, Cas J, et al. "Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study." Open forum infectious diseases vol. 8,2 (2021): ofab006. doi: https://doi.org/10.1093/ofid/ofab006
Isfordink CJ, van de Laar TJW, Rebers SPH, Wessels E, Molenkamp R, Knoester M, Baak BC, van Nieuwkoop C, van Hoek B, Brakenhoff SM, Blokzijl H, Arends JE, van der Valk M, Schinkel J. Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study. Open Forum Infect Dis. 2021 Jan 06;8(2):ofab006. doi: 10.1093/ofid/ofab006. eCollection 2021 Feb. PMID: 33614815; PMCID: PMC7881754.
Copy Download .nbib Format: NLM
Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle.

Research and practice in thrombosis and haemostasis

Blokzijl J, Timmer MA, van Vulpen LFD.
PMID: 34988353
Res Pract Thromb Haemost. 2021 Dec 22;5(8):e12639. doi: 10.1002/rth2.12639. eCollection 2021 Dec.

No abstract available.

Cite
Blokzijl J, Timmer MA, van Vulpen LFD. Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Res Pract Thromb Haemost. 2021;5(8):e12639doi: 10.1002/rth2.12639.
Blokzijl, J., Timmer, M. A., & van Vulpen, L. F. D. (2021). Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Research and practice in thrombosis and haemostasis, 5(8), e12639. https://doi.org/10.1002/rth2.12639
Blokzijl, Johan, et al. "Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle." Research and practice in thrombosis and haemostasis vol. 5,8 (2021): e12639. doi: https://doi.org/10.1002/rth2.12639
Blokzijl J, Timmer MA, van Vulpen LFD. Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Res Pract Thromb Haemost. 2021 Dec 22;5(8):e12639. doi: 10.1002/rth2.12639. eCollection 2021 Dec. PMID: 34988353; PMCID: PMC8694742.
Copy Download .nbib Format: NLM
Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients.

Journal of clinical medicine

Rodrigues FG, Swarte JC, Douwes RM, Knobbe TJ, Sotomayor CG, Blokzijl H, Weersma RK, Heilberg IP, Bakker SJL, de Borst MH, TransplantLines Investigators.
PMID: 34203151
J Clin Med. 2021 Jun 28;10(13). doi: 10.3390/jcm10132854.

BACKGROUND: Diarrhea is common among kidney transplant recipients (KTR). Exhaled hydrogen (HMETHODS: Clinical, laboratory, and dietary data were analyzed from 424 KTR participating in the TransplantLines Biobank and Cohort Study (NCT03272841). Fasting exhaled HRESULTS: KTR (55.4 ± 13.2 years,...

Cite
Rodrigues FG, Swarte JC, Douwes RM, et al. Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients. J Clin Med. 2021;10(13)doi: 10.3390/jcm10132854.
Rodrigues, F. G., Swarte, J. C., Douwes, R. M., Knobbe, T. J., Sotomayor, C. G., Blokzijl, H., Weersma, R. K., Heilberg, I. P., Bakker, S. J. L., de Borst, M. H., & TransplantLines Investigators. (2021). Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients. Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132854
Rodrigues, Fernanda Guedes, et al. "Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients." Journal of clinical medicine vol. 10,13 (2021). doi: https://doi.org/10.3390/jcm10132854
Rodrigues FG, Swarte JC, Douwes RM, Knobbe TJ, Sotomayor CG, Blokzijl H, Weersma RK, Heilberg IP, Bakker SJL, de Borst MH, TransplantLines Investigators. Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients. J Clin Med. 2021 Jun 28;10(13). doi: 10.3390/jcm10132854. PMID: 34203151; PMCID: PMC8267713.
Copy Download .nbib Format: NLM
Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle.

Research and practice in thrombosis and haemostasis

Blokzijl J, Timmer MA, van Vulpen LFD.
PMID: 34988353
Res Pract Thromb Haemost. 2021 Dec 22;5(8):e12639. doi: 10.1002/rth2.12639. eCollection 2021 Dec.

No abstract available.

Cite
Blokzijl J, Timmer MA, van Vulpen LFD. Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Res Pract Thromb Haemost. 2021;5(8):e12639doi: 10.1002/rth2.12639.
Blokzijl, J., Timmer, M. A., & van Vulpen, L. F. D. (2021). Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Research and practice in thrombosis and haemostasis, 5(8), e12639. https://doi.org/10.1002/rth2.12639
Blokzijl, Johan, et al. "Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle." Research and practice in thrombosis and haemostasis vol. 5,8 (2021): e12639. doi: https://doi.org/10.1002/rth2.12639
Blokzijl J, Timmer MA, van Vulpen LFD. Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle. Res Pract Thromb Haemost. 2021 Dec 22;5(8):e12639. doi: 10.1002/rth2.12639. eCollection 2021 Dec. PMID: 34988353; PMCID: PMC8694742.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries